Answers are grounded in this paper and cite their sources.
Fungal infections are an increasing global health concern, with Candida albicans emerging as a leading cause of mucosal and life-threatening systemic infections. C. albicans relies on yeast-to-hyphae transition, to establish systemic infections in the host. Our recent work demonstrated that glycolysis is a key regulator of hyphal differentiation in C. albicans. Leveraging this knowledge, we screened a small-molecule compound library containing glycolysis inhibitors for their ability to block fungal morphogenesis and identified multiple small molecules that robustly block hyphal differentiation without compromising overall growth. Among these, two compounds (PKM2-IN-6 and NPD10084, both originally identified as modulators of human pyruvate kinase M2 (Pkm2) activity) emerged as the most potent inhibitors of fungal morphogenesis, significantly attenuating hyphal differentiation, in multiple filamentation-inducing conditions. Comparative RNA-Seq analysis revealed significant perturbation of glycolysis following PKM2-IN-6 treatment, while molecular docking analysis predicted that these compounds bind to specific pockets of pyruvate kinase in C. albicans. Interestingly, PKM2-IN-6 treatment resulted in the repression of multiple genes associated with fungal morphogenesis, biofilm formation, and virulence. These transcriptional changes were accompanied by a significant reduction in biofilm formation and increased sensitivity to conventional antifungal drugs, including amphotericin B and fluconazole, in the presence of both compounds, PKM2-IN-6 and NPD10084. Furthermore, administration of PKM2-IN-6 significantly improved the survival of mice in a murine model of systemic candidiasis underscoring the in vivo efficacy of this compound. Collectively, our study has identified novel small molecules that target fungal morphogenesis and virulence in C. albicans, establishing inhibition of glycolysis as a promising antifungal strategy.
No takes yet. Share an insight, caveat, or question.
Shah et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: